Abstract 10 Interim Results of a Phase I Study Investigating a Cord Blood-Derived Natural Killer Cell Therapy for Patients Hospitalized with COVID-19

INTRODUCTION: In the setting of viral infections, including infection with SARS-CoV-2, lymphocyte exhaustion and lymphopenia are common. Patients with COVID-19 who develop lymphopenia, particularly low numbers of circulating natural killer (NK) cells, are at high risk for disease progression. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tercero, Almudena, Finlay, Dan, Asghedom, Liya H, Romasanta, Gladys R, Rice, Natalie T, Ranjbaran, Fatima, Stoltzman, Carrie, Cook, Jody, Blake, Joe, Delaney, Colleen, Hill, Joshua A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trials – Hematopoietic Stem Cell Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446918/
http://dx.doi.org/10.1093/stcltm/szac057.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446918/
http://dx.doi.org/10.1093/stcltm/szac057.010

Ejemplares similares